With the firm registered in Wyoming in 2021, but identified as in Dallas TX for its first SBIR Award with the actual work on the project indicated as being undertaken in the Downstate Biotechnology Incubator in Brooklyn NY, it is a little difficult to know how to assign White Rock Therapetics geographically. That noted, the areas of expertise of the firm's President and PI, organize around G-protein-coupled receptor (GPCR) signaling, biochemistry and pharmacology; Single-molecule FRET, Protein X-ray Crystallography, Structural Biology, Biochemistry, Molecular Biophysics
